A MUM has revealed she has no regrets about spending £1,200 on confidence-boosting Mounjaro – despite being in £21,000 of ...

According to leaders in obesity and nutrition research, following these key nutrition guidelines will make the most of GLP-1 ...

Are you tired of boring dieting and gruesome workouts? Then, medical weight loss treatment can be a solution for you. But ...

Are you weening yourself off a compounded version of the drug? Considering switching insurers in order to keep your ...

Berberine, a compound found in various plants, may help to lower blood sugar levels and protect gut health. Available as a ...

New licensing agreement with Hansoh Pharma provides Regeneron with HS-20094, a GLP-1/GIP receptor agonist in advanced st ...

Regeneron Pharmaceuticals has signed a new licensing agreement with Hansoh Pharmaceuticals Group to develop and sell its weight loss therapy outside of China.

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...

For adults with diabetes and obesity, GLP-1 RAs are associated with a reduced risk for obesity-related cancer compared with DPP-4 inhibitors.

Compounded vs non-compounded GLP-1 RA drug products are associated with an increased risk for adverse events such as nausea and diarrhea.